Alan B. Colberg
Alan B. Colberg's purchase track record
Alan B. Colberg has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/21/2023 | USB | $341K | +16.4% | -4.9% | +2.2% |
| 11/10/2022 | CRBG | $687K | -5.2% | -24.9% | +4.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
U.S. Bancorp Q3 Earnings Beat Drives Stock Climb and Analyst Upgrade. U.S. Bancorp reported a strong third-quarter earnings beat, reinforcing resilience through commercial and consumer credit demand. The positive results led to the stock climbing and prompted an analyst upgrade. Fee diversification and deposit growth also supported the company's recent momentum.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Analysts Raise AIZN Price Target 13.72% to $19.99. Analysts have raised the consensus price target for Assurant's 2061 subordinated notes by 13.72% to $19.99, suggesting improving sentiment toward the insurer's credit outlook. The notes currently trade near support at $19.09 with an RSI of 28.6, indicating technical oversold conditions. This upward revision in price targets may reflect views that the notes are undervalued at current levels.
Transaction History
| CRBG | ▲ Buy | Grant | 6,553 | $0 | 6/18/2026 | View on chart |
| CRBG | ▲ Buy | Grant | 5,007 | $0 | 6/3/2025 | View on chart |
| CRBG | ▲ Buy | Grant | 5,563 | $0 | 6/21/2024 | View on chart |
| CRBG | ▲ Buy | Grant | 9,981 | $0 | 6/20/2023 | View on chart |
| USB | ▲ Buy | Open Market | 10,000 | $341K | 4/21/2023 | View on chart |
| CRBG | ▲ Buy | Open Market | 9,392 | $210K | 11/10/2022 | View on chart |
| CRBG | ▲ Buy | Open Market | 20,608 | $477K | 11/10/2022 | View on chart |
| CRBG | ▲ Buy | Grant | 7,858 | $0 | 9/15/2022 | View on chart |
| AIZN | ▼ Sell | Open Market | 11,792 | $1.9M | 11/5/2021 | View on chart |
| AIZN | ▼ Sell | Open Market | 1,608 | $268K | 11/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Corebridge Financial to Report Q3 2026 Results
Corebridge Financial has announced the schedule for its third-quarter 2026 financial results. Separately, industry news indicates that BHF's Shield Annuities are maintaining strong sales growth. The stock currently trades with a dividend yield of 4.43% and an average analyst target of $38.83.
Corebridge Financial to Report Q3 2026 Results. Corebridge Financial has announced the schedule for its third-quarter 2026 financial results. Separately, industry news indicates that BHF's Shield Annuities are maintaining strong sales growth. The stock currently trades with a dividend yield of 4.43% and an average analyst target of $38.83.